DR |
diabetic retinopathy |
AMD |
age-related macular degeneration |
TGFβ |
transforming growth factor β |
CNS/PNS |
central and peripheral nervous systems, |
BDNF |
Brain-derived neurotrophic factor |
NGF |
nerve growth factor |
NT-3 |
neurotrophin-3 |
NT-4/5 |
neurotrophin-4/5 |
TrkA–C |
tropomyosin receptor kinase A–C |
p75NTR
|
neurotrophin receptor p75 |
TGFβR1/2 |
TGFβ receptor types 1 and 2 |
BMP |
bone morphogenetic protein |
GDF |
growth differentiation factors |
ALK1/5 |
activin A receptor like type 1/5 |
SMAD |
abbreviation refers to “small worm phenotype” (SMA) and “mother against decapentaplegic” (MAD), which are homologs of C. elegans and drosophila |
ECM |
extracellular matrix |
MI |
myocardial infraction |
BAX |
BCL2 Associated X, Apoptosis Regulator |
BCL2 |
BCL2 Apoptosis Regulator |
VEGF |
vascular endothelial growth factor |
CAP |
capsaicin |
GW788388 |
small-molecule inhibitor of TGFβR1 |
BRB |
blood-retinal barrier |
BBB |
blood-brain barrier |
RPE |
retinal pigment epithelium |
RGC |
retinal ganglion cells |
CNV |
choroidal neovascularization |
tPA |
tissue plasminogen activator |
NSC |
neuronal stem cells |
t/pMCAO |
transient or permanent middle cerebral artery occlusion |
eNOS |
endothelial nitric oxide synthase |
ENG |
endoglin |